Extract
Erythrocyte abnormalities have been demonstrated to be associated with increased risk of cardiovascular disease development and severity, affecting morbidity and mortality [1, 2].
Abstract
Erythrocytes display structural and functional intrinsic defects in patients with pulmonary arterial hypertension. Their clinical relevance as potential biomarkers and their contribution in the disease pathophysiology still need to be defined.https://bit.ly/3idyfoe
Acknowledgements
作者向YannaëlleRousseau在这项研究中的帮助下表示感谢。
脚注
利益冲突:E-M。Jutant,L。Tu,R。Thuillet,V。Picard和A. Huertas没有披露的利益冲突。C. Guignabert向他的机构报告了Acceleron,Janssen,Shouti和MSD的赠款,以及MSD的个人费用。F.父母向她的机构报告了Acceleron,Bayer,Merck和Janssen的赠款,以及在提交工作之外的拜耳和MSD的个人费用。O. Sitbon从Janssen,Bayer,MSD和GSK向其机构报告,以及Janssen,MSD,Acceleron,Gossamer Bio,Bayer,Ferrer,Ferrer,Aop Orphan和GSK的个人费用。洪伯特(M. Humbert)向他的机构汇报了他的机构以及Acceleron,Janssen和Merck的个人费用,以及在提交工作之外的AOP,Acceleron,Janssen和Merck的个人费用。L. Savale向他的机构汇报了他的机构,以及来自Acceleron,Janssen和Merck的个人费用,以及在提交工作之外的拜耳,Janssen和Merck的个人费用。
Support statement: This research was supported by ERS Main Award in Novel Research in Pulmonary Arterial Hypertension 2020 awarded to A. Huertas.
- 已收到September 20, 2021.
- AcceptedMarch 20, 2022.
- 复制right ©The authors 2022. For reproduction rights and permissions contactpermissions{at}ersnet.org